Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts

<p><strong>Background</strong> Current dementia risk scores have had limited success in consistently identifying at-risk individuals across different ages and geographical locations.</p> <p><strong>Objective</strong> We aimed to develop and validate a novel...

Full description

Bibliographic Details
Main Authors: Anatürk, M, Patel, R, Ebmeier, KP, Georgiopoulos, G, Newby, D, Topiwala, A, de Lange, A-MG, Cole, JH, Jansen, MG, Singh-Manoux, A, Kivimäki, M, Suri, S
Format: Journal article
Language:English
Published: BMJ Publishing Group 2023
_version_ 1826310672532635648
author Anatürk, M
Patel, R
Ebmeier, KP
Georgiopoulos, G
Newby, D
Topiwala, A
de Lange, A-MG
Cole, JH
Jansen, MG
Singh-Manoux, A
Kivimäki, M
Suri, S
author_facet Anatürk, M
Patel, R
Ebmeier, KP
Georgiopoulos, G
Newby, D
Topiwala, A
de Lange, A-MG
Cole, JH
Jansen, MG
Singh-Manoux, A
Kivimäki, M
Suri, S
author_sort Anatürk, M
collection OXFORD
description <p><strong>Background</strong> Current dementia risk scores have had limited success in consistently identifying at-risk individuals across different ages and geographical locations.</p> <p><strong>Objective</strong> We aimed to develop and validate a novel dementia risk score for a midlife UK population, using two cohorts: the UK Biobank, and UK Whitehall II study.</p> <p><strong>Methods</strong> We divided the UK Biobank cohort into a training (n=176 611, 80%) and test sample (n=44 151, 20%) and used the Whitehall II cohort (n=2934) for external validation. We used the Cox LASSO regression to select the strongest predictors of incident dementia from 28 candidate predictors and then developed the risk score using competing risk regression.</p> <p><strong>Findings</strong> Our risk score, termed the UK Biobank Dementia Risk Score (UKBDRS), consisted of age, education, parental history of dementia, material deprivation, a history of diabetes, stroke, depression, hypertension, high cholesterol, household occupancy, and sex. The score had a strong discrimination accuracy in the UK Biobank test sample (area under the curve (AUC) 0.8, 95% CI 0.78 to 0.82) and in the Whitehall cohort (AUC 0.77, 95% CI 0.72 to 0.81). The UKBDRS also significantly outperformed three other widely used dementia risk scores originally developed in cohorts in Australia (the Australian National University Alzheimer’s Disease Risk Index), Finland (the Cardiovascular Risk Factors, Ageing, and Dementia score), and the UK (Dementia Risk Score).</p> <p><strong>Clinical implications</strong> Our risk score represents an easy-to-use tool to identify individuals at risk for dementia in the UK. Further research is required to determine the validity of this score in other populations.</p>
first_indexed 2024-03-07T07:55:24Z
format Journal article
id oxford-uuid:06f0329e-60fe-430e-a627-1a84050334a7
institution University of Oxford
language English
last_indexed 2024-03-07T07:55:24Z
publishDate 2023
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:06f0329e-60fe-430e-a627-1a84050334a72023-08-24T11:54:02ZDevelopment and validation of a dementia risk score in the UK Biobank and Whitehall II CohortsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:06f0329e-60fe-430e-a627-1a84050334a7EnglishSymplectic ElementsBMJ Publishing Group2023Anatürk, MPatel, REbmeier, KPGeorgiopoulos, GNewby, DTopiwala, Ade Lange, A-MGCole, JHJansen, MGSingh-Manoux, AKivimäki, MSuri, S<p><strong>Background</strong> Current dementia risk scores have had limited success in consistently identifying at-risk individuals across different ages and geographical locations.</p> <p><strong>Objective</strong> We aimed to develop and validate a novel dementia risk score for a midlife UK population, using two cohorts: the UK Biobank, and UK Whitehall II study.</p> <p><strong>Methods</strong> We divided the UK Biobank cohort into a training (n=176 611, 80%) and test sample (n=44 151, 20%) and used the Whitehall II cohort (n=2934) for external validation. We used the Cox LASSO regression to select the strongest predictors of incident dementia from 28 candidate predictors and then developed the risk score using competing risk regression.</p> <p><strong>Findings</strong> Our risk score, termed the UK Biobank Dementia Risk Score (UKBDRS), consisted of age, education, parental history of dementia, material deprivation, a history of diabetes, stroke, depression, hypertension, high cholesterol, household occupancy, and sex. The score had a strong discrimination accuracy in the UK Biobank test sample (area under the curve (AUC) 0.8, 95% CI 0.78 to 0.82) and in the Whitehall cohort (AUC 0.77, 95% CI 0.72 to 0.81). The UKBDRS also significantly outperformed three other widely used dementia risk scores originally developed in cohorts in Australia (the Australian National University Alzheimer’s Disease Risk Index), Finland (the Cardiovascular Risk Factors, Ageing, and Dementia score), and the UK (Dementia Risk Score).</p> <p><strong>Clinical implications</strong> Our risk score represents an easy-to-use tool to identify individuals at risk for dementia in the UK. Further research is required to determine the validity of this score in other populations.</p>
spellingShingle Anatürk, M
Patel, R
Ebmeier, KP
Georgiopoulos, G
Newby, D
Topiwala, A
de Lange, A-MG
Cole, JH
Jansen, MG
Singh-Manoux, A
Kivimäki, M
Suri, S
Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title_full Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title_fullStr Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title_full_unstemmed Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title_short Development and validation of a dementia risk score in the UK Biobank and Whitehall II Cohorts
title_sort development and validation of a dementia risk score in the uk biobank and whitehall ii cohorts
work_keys_str_mv AT anaturkm developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT patelr developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT ebmeierkp developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT georgiopoulosg developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT newbyd developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT topiwalaa developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT delangeamg developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT colejh developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT jansenmg developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT singhmanouxa developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT kivimakim developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts
AT suris developmentandvalidationofadementiariskscoreintheukbiobankandwhitehalliicohorts